News

Replimune down as FDA’s top cancer drug regulator reportedly intervened in drug rejection
Shares of Replimune (NASDAQ:REPL) plunged ~38% in the premarket on Monday after Stat News reported that the FDA’s top ...
STAT3h
FDA’s top cancer drug regulator played key role in rejection of Replimune therapy, officials say
The FDA's top regulator of cancer drugs played a key role in the rejection of a skin cancer therapy from Replimune Group, ...
CSP Daily News2d
FDA takes steps to restrict 7-OH
The Food and Drug Administration (FDA) on Tuesday said it is recommending a scheduling action to control certain ...
FDA looking to make vapes less addictive as agency head claims 85% of those sold are ‘illegal’
“First of all, 85 percent of vaping products sold at your local vape shop are illegal,” he told Rob Schmitt Tonight. “These ...
FDA employees say the agency's Elsa generative AI hallucinates entire studies
The federal agency introduced Elsa last month, boasting about the AI tool's ability to increase efficiency at the FDA.
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
Fierce Healthcare2d
FDA requires label changes to all opioid pain meds to clarify risks
The FDA is requiring safety labeling changes to all opioid painkillers, to better highlight the risks posed by using the ...